| Dr Andre Jouve, Project Officer, DG Research & Innovation, European Commission Opening address |
| Professor Angela McLean, University of Oxford Martin School restatement on the health effects of ionizing radiation |
| Professor Ragnar Löfstedt, Kings College London Evidence based risk communication; Learning from examples |
|
| Professor Ortwin Renn, Stuttgart University Communicating Uncertainty and Ambiguity: The bridge between science and policy |
| Dr John Boice, NCRP/Vanderbilt Uni Radiation Epidemiology Supports LNT for Radiation Protection |
|
| Dr Markus Eidemüller, HMGU LNT - is nature linear? |
|
| Prof. Richard Wakeford, UNIMAN For now, LNT is the prudent option |
|
| Dr Antonella Tabocchini, ISS Challenging the LNT model: lines of evidence for sublinear cancer risk Extrapolation |
|
| Prof Kevin Prise, Queen's University Belfast Is the cancer risk from low dose radiation greater than expectations from LNT? |
|
| Dr Radu A. Vasilache, Canberra Packard SRL The Foundations of Radiological Protection: How Would the Acknowledgement of the LNT Failure Change Them? |
|
| Dr Ausra Kesminiene, IARC Cancer Mortality in the International Cohort Study of Radiation Workers (INWORKS) |
| Dr Andrzej Wojcik, Stockholm University Health risks of combined exposures to chemicals and ionising radiation - what is known and what is not |
|
| Dr Rodolphe Gilbin, IRSN Ecological risk of mixtures of radioactive and stable chemical compounds predicted by multi-substance SSD |
|
| Dr Olivier Laurent, IRSN New job exposure matrices for epidemiological studies in French uranium workers |
|
| Zölzer, Institute of Radiologie, Toxicology, and Civil Protection, University of South Bohemia in České Budějovice The Balance between Chemical and IR Risks - Ethical Aspects |
| Dr Weibo Li, HMGU Personalised Dose Assessment for Nuclear Medicine |
|
| Dr Alexander Ulanovsky/Dr Cristoforo Simonetto, HMGU The PASSOS project: assessing personalised risks of late health effects for optimisation of medical applications of radiation |
|
| Dr Ursula Oestreicher, BfS Automated scoring of dicentric chromosomes to investigate age dependent radiosensitivity after Computer Tomography |
|
| Prof Christoph Hoeschen, Otto‐von‐Guericke University Magdeburg Options for personalized medical radiation protection and how to implement it |
| Prof. Steve Horvath, University of California Los Angeles Epigenetics and its impact on health |
| Dr Simon Bouffler, Public Health England Stem cell biology in relation to radiation cancer risk - the RISK‐IR project |
| Dr Odilia Popanda, DKFZ Epigenetics in radiotherapy‐induced fibrosis - differential DNA methylation of diacylglycerol kinase alpha as a novel target |
|
| Prof. Olga Kovalchuk, University of Lethbridge Radiation epigenetics and precision medicine |
|
| Dr Ghada Elmhiri, IRSN DNA methylation and potential multigenerational epigenetic effects related to natural uranium chronic low dose exposure in males and females rats |
|
| Dr Nele Horemans, SCK.CEN Gamma radiation induces an oxidative stress‐response in Oriza sative: the possible regulation through specific miRNA |
|
| Dr Catherine Lecomte‐Paradines, IRSN Contribution of epigenetic processes in the transgenerational toxicity of chronic gamma radiation |
| Dr Anne Nisbet, PHE From bi‐lateral discussions to multinational stakeholder networks: we are going in the right direction |
|
| Dr Stéphane Baudé, MUTADIS Democratic culture in radiation protection ‐ theoretical and practical insights |
|
| K.Nadia Papamichail, Manchester University Decision Analysis in the Nuclear Sector |
|
| Dr Gaston Meskens, SCK.CEN Introduction: Stakeholder Engagement: What might go wrong? |
| Prof Roger Harrison, University of Newcastle upon Tyne An introduction - Dose distribution in medical applications - impacts |
|
| Prof. Dr Wolfgang Doerr, Medical University of Vienna Requirements for the specification of anatomical dose distributions in risk estimation and treatment plan optimisation in radiotherapy |
|
| Dr Andrzej Wojcik, Stockholm University Evidence for synergistic interaction of low and high LET radiation ‐ significance for radiation protection |
|
| Prof. John Harrison, ICRP 2 Use of Effective Dose |
|
| Dr Anja Alm én/ Dr Soeren Mattsson, Lund University Is individual dose assessment and risk estimation in diagnostic imaging needed? |
|
| Dr Elisa Pasqual, ISGlobal Nested case control study in a cohort of patients exposed to CT scan during their childhood |
|
| Prof Klaus Trott, Helmholtz Zentrum München Effective dose: a flawed concept that could and should be replaced |
| Prof. John Harrison, ICRP 2 An introduction - Circulatory diseases - should they be included in radiation detriment ? |
|
| Dr Dominique Laurier, IRSN Radiation induced risk of circulatory disease: what potential impact on detriment? |
|
| Prof Richard Wakeford, UNIMAN Insufficient evidence for low‐level radiation increasing the risk of circulatory disease |
|
| Dr Ken Raj, PHE Biological perspective on the effects of radiation on cardiovascular disease |
|
| Dr Cristoforo Simonetto, HMGU A Mechanistic Model for Atherosclerosis and its Application to Stroke in Mayak Workers |
| Dr Eduardo Gallego, Universidad Politecnica de Madrid Protection of the environment and protection of humans - striking the correct balance |
|
| Dr Philippe Ciffroy, EDF R&D Perspectives for integrating human and environmental risk assessments: the HEROIC project's findings |
|
| Prof. David Copplestone, University of Stirling Applying the system of radiological protection: similarities and differences for human and wildlife protection |
|
| Dr Rodolphe Gilbin, IRSN Towards integrated protection criteria for human health and environment for Uranium in freshwaters |
|
| Dr Ivica Prlic, Institute for Medical Research and
Occupational Health Environmental Monitoring System - the IPPSO project |
| Dr Sam Behjati, Wellcome Trust Sanger Institute Genetic signatures of radiation‐induced cancers |
|
| Dr Kalliopi Manola, NCSR "DEMOKRITOS" DNA polymorphisms in detoxifying genes and leukaemia |
|
| Dr Serge Candeias, CEA Long term alteration of mouse TCR repertoire following radiation exposure |
|
| Dr Rhona Anderson, Brunel University London Track structure with relation to cell geometry and aberration types induced |
|
| Dr Giorgio Baiocco, University of Pavia An ab‐initio approach to trace back the physical origin of neutron biological effectiveness as a function of energy |
| Mr Richard A Paynter Overview of EUTERP |
|
| Dr Tatiana Duranova, VUJE and Dr Deborah Oughton, NMBU NERIS |
|
| Dr Miquel Vidal, University of Barcelona Education and training in the ALLIANCE |
|
| Dr Joao H. Garcia Alves, IST/ITN EURADOS Education and Training |
|
| Dr Vere Smyth, University of Pavia Education & Training in the MELODI platform |
|
| Dr Vere Smyth, University of Pavia Education & Training in the CONCERT European Joint Programme |
| Dr Jean‐Rene Jourdain, IRSN Introduction to the OPERRA project |
|
| Dr Lara Struelens, SCK.CEN Retrospective assessment of eye lens doses for interventional cardiologists |
|
| Dr Christophe Gueibe/Dr Johan Camps, SCK.CEN HARMONE WP4 -Monitoring strategies |
|
| Dr Christian Staudt, HMGU OPERRA‐HARMONE Regionalization of dose assessment |
|
| Dr Serge Candeias, CEA VIBRATO ‐ Validation in vivo of immune biological indicators of radiation exposure to use for emergency situations, the determination of health effects and molecular epidemiology. |
|
| Dr Rafael García‐Tenorio, University of Sevilla RATE‐ RAdioactive particle Transformation procEsses: A research project inside COMET |
|
| Dr Nele Horemans, SCK.CEN The impact of Recent Releases from the Fukushima Nuclear Accident on the Marine Environment |
| Dr Ulrike Kulka, BfS; Dr Clemens Woda, Helmholtz Zentrum München An introduction - Retrospective Dosimetry workshop |
|
| Dr Roel Quintens, SCK.CEN Can RENEB help answer research questions in molecular epidemiology and if yes, how? |
|
| Dr Andrzej Wojcik, Stockholm University Dosimetry methods to aid emergency decision making and long‐term follow up: Status quo and way forward |
|
| Dr Liz Ainsbury, PHE How certain is uncertainty in retrospective dosimetry? |
| Dr Michaela Kreuzer, BfS Leukemia mortality and low dose ionizing radiation in the Wismut uranium miner cohort |
|
| Dr Jochen Graw, HMGU Low‐dose ionizing radiation‐induced cataracts in the mouse ‐ a lifetime study |
|
| Dr Simon Bouffler, PHE Update of MELODI SRA, priorities and roadmap |
| Dr Pascal Crouail, CEPN First feedback analysis of the lifting of evacuation order in the Fukushima Prefecture |
|
| Dr Anne Nisbet, PHE Lifting of countermeasures in the case of Cumbria. |
Professor Deborah Oughton, CERAD, NMBU Challenges with the evolution of Countermeasures on Reindeer in Norway |
| Dr Wolfgang Raskob, KIT The role of Decision Support System in planning the lifting of countermeasures |
| Dr Augusto Giussani, BfS Internal doses and uncertainties: the point of view of the dosimetrist |
|
| Dr Sophie Ancelet, IRSN Internal doses and uncertainties: the point of view of the epidemiologist |
|
| Dr Sandrine Roch‐Lefevre, IRSN Induction of Chromosome Damage in Mice Chronically Exposed in vivo to Low Dose Internal Tritium Beta‐Particle and External Gamma‐Radiation |
|
| Dr Balazs Madas, MTA Centre for Energy Research Radon induced hyperplasia: effective adaptation reducing the local doses in the bronchial epithelium |
|
| Dr Bastian Breustedt, Karlsruhe Institute of Technology Studying uncertainties of internal doses due to variability in biokinetic models by statistical modelling of parameter values |
| Dr Jorden van de Walle, SCK.CEN Exposure of Arabidopsis thaliana to gamma radiation over different generations: contribution of epigenetic processes to the induction of long‐term effects |
|
| Dr Anne Graupner, Norwegian Institute of Public Health Genotoxic and epigenetic effects of different low dose rates of gamma radiation in three mouse strains |
|
| Tobias Dressel, PTB Braunschweig Monte Carlo study of the locally enhanced DNA damage around gold nanoparticles |
|
| Dr Liz Ainsbury, PHE COST Proposal - European Cooperation in Science and Technology |
|
| Ignazio Vilardi, ENEA Fast monitoring of internally contaminated public following a radiation accident |
| Uta Eberlein, University Hospital Würzburg, Department of Nuclear Medicine Relationship between internal dosimetry and DNA double strand breaks in lymphocytes after radionuclide therapy |
| Dr Michaela Kreuzer, BfS Feedback from MELODI SRA WG |
|
| Dr Werner Rüehm, Helmholtz Zentrum München Feedback from EURADOS SRA Working Group |
|
| Dr Johan Camps, SCK.CEN NERIS R&D Committee feedback |
|
| Dr Jacqueline Garnier‐Laplace, IRSN ALLIANCE Feedback - Impact on SRA |
|
| Prof Christoph Hoeschen, Helmholtz Zentrum München Feedback from EURAMED |
|
| Dr Tanja Perko, SCK.CEN SSH feedback |